Credit Suisse’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.18M | Buy |
46,547
+6,163
| +15% | +$156K | ﹤0.01% | 2162 |
|
|
2023
Q4 | $943K | Sell |
40,384
-2,811
| -7% | -$65.6K | ﹤0.01% | 2360 |
|
|
2023
Q3 | $2.18M | Sell |
43,195
-7,424
| -15% | -$376K | ﹤0.01% | 1777 |
|
|
2023
Q2 | $2.36M | Buy |
50,619
+22,538
| +80% | +$1.05M | ﹤0.01% | 1786 |
|
|
2023
Q1 | $1.07M | Buy |
28,081
+1,442
| +5% | +$55.2K | ﹤0.01% | 2265 |
|
|
2022
Q4 | $1.46M | Buy |
26,639
+13,663
| +105% | +$749K | ﹤0.01% | 2058 |
|
|
2022
Q3 | $441K | Buy |
12,976
+149
| +1% | +$5.06K | ﹤0.01% | 2840 |
|
|
2022
Q2 | $122K | Buy |
12,827
+1,649
| +15% | +$15.7K | ﹤0.01% | 3477 |
|
|
2022
Q1 | $159K | Buy |
11,178
+340
| +3% | +$4.84K | ﹤0.01% | 3405 |
|
|
2021
Q4 | $229K | Sell |
10,838
-19,734
| -65% | -$417K | ﹤0.01% | 3399 |
|
|
2021
Q3 | $682K | Buy |
30,572
+20,235
| +196% | +$451K | ﹤0.01% | 2819 |
|
|
2021
Q2 | $256K | Sell |
10,337
-878
| -8% | -$21.7K | ﹤0.01% | 3343 |
|
|
2021
Q1 | $326K | Sell |
11,215
-17,288
| -61% | -$503K | ﹤0.01% | 3134 |
|
|
2020
Q4 | $735K | Buy |
28,503
+18,624
| +189% | +$480K | ﹤0.01% | 2768 |
|
|
2020
Q3 | $304K | Buy |
+9,879
| New | +$304K | ﹤0.01% | 2912 |
|